Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine
| Autor: | Peter Múdry, L. Zdrazilova Dubska, Pavel Mazánek, Kateřina Pilátová, Lenka Fedorova, Jaroslav Sterba, Eva Hlaváčková |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0303 health sciences
business.industry Monocyte derived Monocyte Hematology Dendritic cell medicine.disease Peripheral blood mononuclear cell 3. Good health 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Pharmacotherapy Oncology 030220 oncology & carcinogenesis Neuroblastoma Cancer research Medicine Potency Sarcoma business 030304 developmental biology |
| Zdroj: | Annals of Oncology. 30:xi13 |
| ISSN: | 0923-7534 |
| Popis: | Refractory and relapsing sarcoma and high-risk neuroblastoma show poor prognoses. Monocyte-derived dendritic cell anticancer vaccine could extend the treatment modalities in these patients. Pharmacotherapy prior to mononuclear cell harvest may influence the quality of manufactured dendritic cell product. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|